Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207). Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing.  Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.  Oppose reductions to Medicare Clinical Laboratory Fee Schedule.
MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
STONE MATTHEIS XENOPOULOS AND BREW, PC
1025 THOMAS JEFFERSON STREET, NW. #800 W, WASHINGTON, DC, 20007, US
MICHAEL N MCCARTY PATRICK BURCHETTE MICHAEL N MCCARTY PATRICK BURCHETTE